Menu
Search
|

Menu

Close
X

Zimmer Biomet Holdings Inc ZBH.N (New York Stock Exchange)

112.24 USD
-0.14 (-0.12%)
As of Jul 19
chart
Previous Close 112.38
Open 112.30
Volume 157,365
3m Avg Volume 270,459
Today’s High 112.56
Today’s Low 111.17
52 Week High 132.14
52 Week Low 104.28
Shares Outstanding (mil) 202.20
Market Capitalization (mil) 24,115.91
Forward P/E 34.03
Dividend (Yield %) 0.24 ( 0.80 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.15 Mean rating from 27 analysts

KEY STATS

Revenue (mm, USD)
FY18
2,018
FY17
7,819
FY16
7,684
FY15
5,998
EPS (USD)
FY18
0.854
FY17
2.662
FY16
1.509
FY15
0.715
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
34.03
32.76
Price to Sales (TTM)
vs sector
3.10
5.73
Price to Book (MRQ)
vs sector
2.35
5.47
Price to Cash Flow (TTM)
vs sector
13.53
23.29
Total Debt to Equity (MRQ)
vs sector
103.94
16.84
LT Debt to Equity (MRQ)
vs sector
91.01
12.51
Return on Investment (TTM)
vs sector
3.00
14.61
Return on Equity (TTM)
vs sector
7.18
16.34

EXECUTIVE LEADERSHIP

Larry Glasscock
Independent Non-Executive Chairman of the Board, Since 2013
Salary: --
Bonus: --
Bryan Hanson
President, Chief Executive Officer, Director, Since 2017
Salary: $36,346.00
Bonus: $573,000.00
Daniel Florin
Chief Financial Officer, Executive Vice President, Since 2018
Salary: $820,597.00
Bonus: $687,234.00
Robert Delps
President, Americas, Since 2017
Salary: --
Bonus: --
Sang Yi
President, Asia Pacific, Since 2015
Salary: $480,372.00
Bonus: $572,683.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

345 E Main St
WARSAW   IN   46580-2746

Phone: +1574.2676131

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

SPONSORED STORIES